MELD-Na: Effective in predicting rebleeding in cirrhosis after cessation of esophageal variceal hemorrhage by endoscopic therapy

Journal of Clinical Gastroenterology

Volumn 48, Issue 10, 2014, Pages 870-877

  Wang, Jian ^a   Wang, An Jiang ^a   Li, Bi Min ^a   Liu, Zhi Jian ^a   Chen, Lu ^a   Wang, He ^a   Shi, Feng ^a   Zhu, Xuan ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

Esophageal variceal hemorrhage; MELD and sodium; Prediction; Rebleeding

Indexed keywords

ADULT; ARTICLE; CHILD TURCOTTE PUGH SCORE; CONTROLLED STUDY; DECOMPENSATED LIVER CIRRHOSIS; DOUBLE BLIND PROCEDURE; ENDOSCOPIC SCLEROTHERAPY; ENDOSCOPIC THERAPY; ESOPHAGEAL VARICEAL HEMORRHAGE; ESOPHAGUS HEMORRHAGE; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE AND SODIUM SCORE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; PREDICTION; PREDICTIVE VALUE; RANDOMIZED CONTROLLED TRIAL; REBLEEDING; YOUDEN INDEX; AREA UNDER THE CURVE; BLOOD; CHINA; COMPARATIVE STUDY; COMPLICATION; END STAGE LIVER DISEASE; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; HEMOSTASIS; LIGATION; LIVER CIRRHOSIS; MIDDLE AGED; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECEIVER OPERATING CHARACTERISTIC; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; SCLEROTHERAPY; TIME; TREATMENT OUTCOME;

BIOLOGICAL MARKER; SODIUM;

ADULT; AREA UNDER CURVE; BIOLOGICAL MARKERS; CHINA; END STAGE LIVER DISEASE; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMOSTASIS, ENDOSCOPIC; HUMANS; LIGATION; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; SCLEROTHERAPY; SODIUM; TIME FACTORS; TREATMENT OUTCOME;

EID: 84916202472     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/mcg.0000000000000043     Document Type: Article

References (28)

1. D'Amico G, De Franchis R. Upper digestive bleeding in cirrhosis. Post-Therapeutic outcome and prognostic indicators. Hepatology. 2003;38: 599-612.
2. Carbonell N, Pauwels A, Serfaty L, et al. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology. 2004;40: 652-659.
3. Mihas AA, Sanyal AJ. Recurrent variceal bleeding despite endoscopic and medical therapy. Gastroenterology. 2004;127: 621-629.
4. D'Amico G, Luca A. Natural history. Clinical-haemodynamic correlations. Predication of the risk of bleeding. Bailliere Clinic Gastroenterol. 1997;11: 243-256.
5. Bambha K, Kim WR, Pedersen R, et al. Predictors of early rebleeding and mortality after acute variceal hemorrhage in patients with cirrhosis. Gut. 2008;57: 814-820.
6. Biggins SW, Kim WR, Terrault NA, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology. 2006;130: 1652-1660.
7. Freeman RB, Wiesner RH, Edwards E, et al. Results of the first year of the new liver allocation plan. Liver Transpl. 2004;10: 7-15.
8. Chan HL, Chim AM, Lau JT, et al. Evaluation of model for end-stage liver disease for prediction of mortality in decompensated chronic hepatitis B. Am J Gastroenterol. 2006; 101: 1516-1523.
9. Wong VW, Chim AM, Wong GL, et al. Performance of the new MELD-Na score in predicting 3-month and 1-year mortality in Chinese patients with chronic hepatitis B. Liver Transpl. 2007;13: 1228-1235.
10. Huo TI, Lin HC, Huo SC, et al. Comparison of four model for end-stage liver disease-based prognostic systems for cirrhosis. Liver Transpl. 2008;14: 837-844.
11. de Franchis R. Updating consensus in portal hypertension: Report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol. 2000;33: 846-852.
12. Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60: 646-649.
13. Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003;124: 91-96.
14. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics. 1988;44: 837-845.
15. Krige JE, Kotze UK, Distiller G, et al. Predictive factors for rebleeding and death in alcoholic cirrhotic patients with acute variceal bleeding: A multivariate analysis. World J Surg. 2009;33: 2127-2135.
16. Ben-Ari Z, Cardin F, McCormick AP, et al. A predictive model for failure to control bleeding during acute variceal haemorrhage. J Hepatol. 1999;31: 443-450.
17. Zhao C, Chen SB, Zhou JP, et al. Prognosis of hepatic cirrhosis patients with esophageal or gastric variceal hemorrhage: Multivariate analysis. Hepatobiliary Pancreat Dis Int. 2002;1: 416-419.
18. Poynard T, Lebrec D, Hillon P, et al. Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: A prospective study of factors associated with rebleeding. Hepatology. 1987;7: 447-451.
19. Thomopoulos K, Theocharis G, Mimidis K, et al. Improved survival of patients presenting with acute variceal bleeding. Prognostic indicators of short-and long-term mortality. Dig Liver Dis. 2006;38: 899-904.
20. Bosch J, Berzigotti A, Garcia-Pagan JC, et al. The management of portal hypertension: Rational basis, available treatments and future options. J Hepatol. 2008;48(suppl 1): S68-S92.
21. Avgerinos A, Armonis A, Stefanidis G, et al. Sustained rise of portal pressure after sclerotherapy, but not band ligation, in acute variceal bleeding in cirrhosis. Hepatology. 2004;39: 1623-1630.
22. Monescillo A, Martínez-Lagares F, Ruiz-del-Arbol L, et al. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology. 2004;40: 793-801.
23. de la Mata M, Cuende N, Huet J, et al. Model for end-stage liver disease score based allocation of donors for liver transplantation: A Spanish multicenter experience. Transplantation. 2006;82: 1429-1435.
24. Ahmad J, Downey KK, Akoad M, et al. Impact of the MELD score on waiting time and disease severity in liver transplantation in United States veterans. Liver Transpl. 2007;13: 1564-1569.
25. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies. J Hepatol. 2006;44: 217-231.
26. Jiang M, Liu F, Xiong WJ, et al. Comparison of four models for end-stage liver disease in evaluating the prognosis of cirrhosis. World J Gastroenterol. 2008;14: 6546-6550.
27. Koo JK, Kim JH, Choi YJ, et al. Predictive value of Refit MELD, Refit MELD-Na and pre-existing scoring system for 3 month mortality in Korean patients with cirrhosis. J Gastroenterol Hepatol. 2013;28: 1209-1216.
28. Orloff MJ, Vaida F, Isenberg JI, et al. Child-Turcotte score versus MELD for prognosis in a randomized controlled trial of emergency treatment of bleeding esophageal varices in cirrhosis. J Surg Res. 2012;178: 139-146.